Patents matching “MENS”

EP 3986378

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN IN FORM VON GEL MIT XYLOGLUCAN UND ALKOHOLEN ZUR KONTROLLIERTEN FREISETZUNG VON WIRKSTOFFEN

ALFASIGMA SPA [IT] · Granted Apr 27, 2022 · Expires Apr 22, 2042

EP 3964220

PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON OSTEOPOROSE

BIOCODEX [FR] · Granted Mar 9, 2022 · Expires Mar 4, 2042

US 11040107

Dosing regimens and related compositions and methods

Apellis Pharmaceuticals, Inc. · Granted Jun 22, 2021 · Expires Jun 17, 2041

US 11000520

Buprenorphine dosing regimens

Indivior UK Limited · Granted May 11, 2021 · Expires May 6, 2041

US 2021128573

DOSING REGIMENS FOR USE IN TREATING MYELOFIBROSIS AND MPN-RELATED DISORDERS WITH NAVITOCLAX

ABBVIE INC [US] · Granted May 6, 2021 · Expires May 1, 2041

US 10888558

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

The Government of the United States, as represented by the Secretary of the Army · Granted Jan 12, 2021 · Expires Jan 7, 2041

EP 3752616

ZUSAMMENSETZUNGEN UND VERFAHREN ZUR GENEDITIERUNG DURCH TARGETING VON FIBRINOGEN-ALPHA

CRISPR THERAPEUTICS AG [CH] · Granted Dec 23, 2020 · Expires Dec 18, 2040

US 10786435

Composition for optical three-dimensional modeling

KURARAY NORITAKE DENTAL INC. · Granted Sep 29, 2020 · Expires Sep 24, 2040

US 10517491

Cardiac phase-resolved non-breath-hold 3-dimensional magnetic resonance angiography

The Regents of the University of California · Granted Dec 31, 2019 · Expires Dec 26, 2039

US 10428157

Dosing regimens for use with PCSK9 inhibitors

REGENERON PHARMACEUTICALS, INC. · Granted Oct 1, 2019 · Expires Sep 26, 2039

US 10350256

Compositions for the treatment of dermatological conditions, disorders or diseases

Veit Hoermann Gesellschaft Für Unternehmenskommunikation mbH · Granted Jul 16, 2019 · Expires Jul 11, 2039

US 10342791

Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

The United States of America as represented by the Secretary of the Army · Granted Jul 9, 2019 · Expires Jul 4, 2039

US 10335460

IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions

THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Jul 2, 2019 · Expires Jun 27, 2039

US 10093790

Three-dimensional cellulose molded body, method for the production thereof and use of the same

LENZING AKTIENGESELLSCHAFT · Granted Oct 9, 2018 · Expires Oct 4, 2038

US 10016461

Apparatus and process for growing a heart valve in three-dimensions

The Regents of the University of California · Granted Jul 10, 2018 · Expires Jul 5, 2038

US 9976123

Cellular seeding and co-culture of a three dimensional fibroblast construct

Arizona Board of Regents on Behalf of the University of Arizona · Granted May 22, 2018 · Expires May 17, 2038

EP 3182958

ARIPIPRAZOL-PRODRUGZUSAMMENSETZUNG

ALKERMES PHARMA IRELAND LTD [IE] · Granted Jun 28, 2017 · Expires Jun 23, 2037

US 9675655

Compositions for the treatment of dermatological conditions, disorders or diseases

Veit Hoermann Gesellschaft Für Unternehmenskommunikation mbH · Granted Jun 13, 2017 · Expires Jun 8, 2037

EP 3169322

DIÄTETISCHE ZUSAMMENSETZUNG MIT ANTIDYSLIPIDÄMISCHER AKTIVITÄT

BERLIN-CHEMIE AG [DE] · Granted May 24, 2017 · Expires May 19, 2037

US 9592255

Scaffold-free three dimensional nerve fibroblast constructs

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 14, 2017 · Expires Mar 9, 2037

US 9498468

Rhinitis treatment regimens

Pharmaceutical Design, LLC · Granted Nov 22, 2016 · Expires Nov 17, 2036

WO 2015165821

VERFAHREN UND VORRICHTUNG ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN ZUSAMMENSETZUNG

ACINO SUPPLY AG [CH] · Granted Nov 5, 2015 · Expires Oct 31, 2035

US 9051550

Cellular seeding and co-culture of a three dimensional fibroblast construct

Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 9, 2015 · Expires Jun 4, 2035

EP 2870969

Pharmazeutische Zusammensetzung zur Reduzierung der adipösen Masse

BIOCODEX [FR] · Granted May 13, 2015 · Expires May 8, 2035